Effects of Icariin and Its Metabolites on GPCR Regulation and MK-801-Induced Schizophrenia-Like Behaviors in Mice
Molecules · 2023
DOI: 10.3390/molecules28217300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Su Hui Seong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Natural Products Research, Honam National Institute of Biological Resources, Mokpo 58762, Republic of Korea. Hauptthemen laut MEDLINE: Schizophrenia, Neurodegenerative Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Ministry of Environment (MOE) of the Republic of Korea, Korea Environment Industry & Technology Institute (KEITI).
Abstract (Originalsprache)
Icariin, a major bioactive compound found in the Epimedium genus, has been reported to exert protective effects against neurodegenerative disorders. In the current study, we aimed to investigate the regulatory effect of icariin and its active metabolites (icariside II and icaritin) against prime G-protein-coupled receptor targets, considering their association with neuronal disorders. Icariside II exhibited selective agonist activity towards the dopamine D3 receptor (D3R), with half-maximal effective concentrations of 13.29 μM. Additionally, they effectively inhibited the specific binding of radioligands to D3R. Molecular docking analysis revealed that icariside II potentially exerts its agonistic effect through hydrogen-bonding interaction with Asp110 of the D3R, accompanied by negative binding energy. Conversely, icaritin demonstrated selective antagonist effects on the muscarinic acetylcholine M2 receptor (M2R). Radioligand binding assay and molecular docking analysis identified icaritin as an orthosteric ligand for M2R. Furthermore, all three compounds, icariin and its two metabolites, successfully mitigated MK-801-induced schizophrenia-like symptoms, including deficits in prepulse inhibition and social interaction, in mice. In summary, these findings highlight the potential of icariin and its metabolites as promising lead structures for the discovery of new drugs targeting cognitive and neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Natural Products Research, Honam National Institute of Biological Resources, Mokpo 58762, Republic of Korea.
- Division of Research Management, Honam National Institute of Biological Resources, Mokpo 58762, Republic of Korea.
- Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Food Science and Human Nutrition, Jeonbuk National University, Jeonju 54896, Republic of Korea.
- Department of Food and Life Science, Pukyong National University, Busan 48513, Republic of Korea.
ORCID-Profile: Jae Sue Choi
Förderung
- National Research Foundation of Korea (NRF)
- Ministry of Environment (MOE) of the Republic of Korea
- Korea Environment Industry & Technology Institute (KEITI)
Zitieren
APA
Seong, S. H., Kim, S. H., Ryu, J. H., Jeong, J. W., Jung, H. A., & Choi, J. S. (2023). Effects of Icariin and Its Metabolites on GPCR Regulation and MK-801-Induced Schizophrenia-Like Behaviors in Mice. Molecules. https://doi.org/10.3390/molecules28217300
Vancouver
Seong SH, Kim SH, Ryu JH, Jeong JW, Jung HA, Choi JS. Effects of Icariin and Its Metabolites on GPCR Regulation and MK-801-Induced Schizophrenia-Like Behaviors in Mice. Molecules. 2023. doi:10.3390/molecules28217300
BibTeX
@article{Seong2023,
author = {Seong, Su Hui and Kim, Seo Hyun and Ryu, Jong Hoon and Jeong, Jin-Woo and Jung, Hyun Ah and Choi, Jae Sue},
title = {Effects of Icariin and Its Metabolites on GPCR Regulation and MK-801-Induced Schizophrenia-Like Behaviors in Mice},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28217300}
}
EUVIMED